vs

Side-by-side financial comparison of SunOpta Inc. (STKL) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $205.4M, roughly 1.1× SunOpta Inc.). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 0.4%, a 5.4% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs 9.6%). SunOpta Inc. produced more free cash flow last quarter ($12.1M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 7.4%).

SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

STKL vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.1× larger
UTI
$220.8M
$205.4M
STKL
Growing faster (revenue YoY)
STKL
STKL
+6.9% gap
STKL
16.6%
9.6%
UTI
Higher net margin
UTI
UTI
5.4% more per $
UTI
5.8%
0.4%
STKL
More free cash flow
STKL
STKL
$31.2M more FCF
STKL
$12.1M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
7.4%
STKL

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
STKL
STKL
UTI
UTI
Revenue
$205.4M
$220.8M
Net Profit
$816.0K
$12.8M
Gross Margin
12.4%
Operating Margin
3.3%
7.1%
Net Margin
0.4%
5.8%
Revenue YoY
16.6%
9.6%
Net Profit YoY
113.1%
-42.1%
EPS (diluted)
$0.01
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STKL
STKL
UTI
UTI
Q4 25
$220.8M
Q3 25
$205.4M
$222.4M
Q2 25
$191.5M
$204.3M
Q1 25
$201.6M
$207.4M
Q4 24
$193.9M
$201.4M
Q3 24
$175.9M
$196.4M
Q2 24
$169.5M
$177.5M
Q1 24
$184.4M
$184.2M
Net Profit
STKL
STKL
UTI
UTI
Q4 25
$12.8M
Q3 25
$816.0K
$18.8M
Q2 25
$4.4M
$10.7M
Q1 25
$4.8M
$11.4M
Q4 24
$-8.7M
$22.2M
Q3 24
$-6.2M
$18.8M
Q2 24
$-5.3M
$5.0M
Q1 24
$2.9M
$7.8M
Gross Margin
STKL
STKL
UTI
UTI
Q4 25
Q3 25
12.4%
Q2 25
14.8%
Q1 25
15.0%
Q4 24
10.9%
Q3 24
13.0%
Q2 24
12.5%
Q1 24
16.8%
Operating Margin
STKL
STKL
UTI
UTI
Q4 25
7.1%
Q3 25
3.3%
11.2%
Q2 25
5.5%
6.9%
Q1 25
5.2%
8.1%
Q4 24
1.4%
13.6%
Q3 24
0.5%
13.3%
Q2 24
1.2%
4.2%
Q1 24
5.5%
6.1%
Net Margin
STKL
STKL
UTI
UTI
Q4 25
5.8%
Q3 25
0.4%
8.4%
Q2 25
2.3%
5.2%
Q1 25
2.4%
5.5%
Q4 24
-4.5%
11.0%
Q3 24
-3.5%
9.6%
Q2 24
-3.1%
2.8%
Q1 24
1.6%
4.2%
EPS (diluted)
STKL
STKL
UTI
UTI
Q4 25
$0.23
Q3 25
$0.01
$0.33
Q2 25
$0.03
$0.19
Q1 25
$0.04
$0.21
Q4 24
$-0.08
$0.40
Q3 24
$-0.05
$0.35
Q2 24
$-0.04
$0.09
Q1 24
$0.02
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STKL
STKL
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$2.2M
$162.8M
Total DebtLower is stronger
$250.8M
$101.4M
Stockholders' EquityBook value
$162.8M
$335.9M
Total Assets
$694.1M
$834.0M
Debt / EquityLower = less leverage
1.54×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STKL
STKL
UTI
UTI
Q4 25
$162.8M
Q3 25
$2.2M
$169.1M
Q2 25
$2.2M
$70.7M
Q1 25
$2.3M
$96.0M
Q4 24
$1.6M
$172.0M
Q3 24
$2.9M
$161.9M
Q2 24
$3.2M
$115.5M
Q1 24
$1.5M
$116.1M
Total Debt
STKL
STKL
UTI
UTI
Q4 25
$101.4M
Q3 25
$250.8M
$87.1M
Q2 25
$263.3M
$73.8M
Q1 25
$260.6M
$94.4M
Q4 24
$265.2M
$120.1M
Q3 24
$289.9M
$125.7M
Q2 24
$303.1M
$137.3M
Q1 24
$258.8M
$141.9M
Stockholders' Equity
STKL
STKL
UTI
UTI
Q4 25
$335.9M
Q3 25
$162.8M
$328.1M
Q2 25
$159.8M
$306.8M
Q1 25
$154.8M
$293.9M
Q4 24
$148.6M
$280.0M
Q3 24
$155.0M
$260.2M
Q2 24
$158.8M
$239.4M
Q1 24
$163.6M
$232.6M
Total Assets
STKL
STKL
UTI
UTI
Q4 25
$834.0M
Q3 25
$694.1M
$826.1M
Q2 25
$704.9M
$740.8M
Q1 25
$690.7M
$720.4M
Q4 24
$668.5M
$753.8M
Q3 24
$699.3M
$744.6M
Q2 24
$704.7M
$706.0M
Q1 24
$671.8M
$702.1M
Debt / Equity
STKL
STKL
UTI
UTI
Q4 25
0.30×
Q3 25
1.54×
0.27×
Q2 25
1.65×
0.24×
Q1 25
1.68×
0.32×
Q4 24
1.78×
0.43×
Q3 24
1.87×
0.48×
Q2 24
1.91×
0.57×
Q1 24
1.58×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STKL
STKL
UTI
UTI
Operating Cash FlowLast quarter
$16.3M
$3.1M
Free Cash FlowOCF − Capex
$12.1M
$-19.2M
FCF MarginFCF / Revenue
5.9%
-8.7%
Capex IntensityCapex / Revenue
2.1%
10.1%
Cash ConversionOCF / Net Profit
20.03×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$36.4M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STKL
STKL
UTI
UTI
Q4 25
$3.1M
Q3 25
$16.3M
$57.1M
Q2 25
$-4.5M
$18.1M
Q1 25
$22.3M
$-789.0K
Q4 24
$33.1M
$23.0M
Q3 24
$17.2M
$67.5M
Q2 24
$-5.6M
$10.0M
Q1 24
$5.3M
$-2.5M
Free Cash Flow
STKL
STKL
UTI
UTI
Q4 25
$-19.2M
Q3 25
$12.1M
$40.6M
Q2 25
$-9.2M
$6.8M
Q1 25
$9.5M
$-11.7M
Q4 24
$24.0M
$19.6M
Q3 24
$11.7M
$60.0M
Q2 24
$-15.3M
$3.0M
Q1 24
$-2.3M
$-8.4M
FCF Margin
STKL
STKL
UTI
UTI
Q4 25
-8.7%
Q3 25
5.9%
18.3%
Q2 25
-4.8%
3.4%
Q1 25
4.7%
-5.7%
Q4 24
12.4%
9.7%
Q3 24
6.6%
30.6%
Q2 24
-9.0%
1.7%
Q1 24
-1.2%
-4.6%
Capex Intensity
STKL
STKL
UTI
UTI
Q4 25
10.1%
Q3 25
2.1%
7.4%
Q2 25
2.5%
5.5%
Q1 25
6.3%
5.3%
Q4 24
4.7%
1.7%
Q3 24
3.2%
3.8%
Q2 24
5.7%
4.0%
Q1 24
4.1%
3.2%
Cash Conversion
STKL
STKL
UTI
UTI
Q4 25
0.24×
Q3 25
20.03×
3.04×
Q2 25
-1.03×
1.69×
Q1 25
4.63×
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×
Q1 24
1.83×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STKL
STKL

Beverages And Broths$161.4M79%
Fruit Snacks$40.9M20%
Ingredients$3.1M2%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons